To Evaluate the Efficacy of CVN424 in Parkinson's Disease Participants With Motor Complications

PHASE3RecruitingINTERVENTIONAL
Enrollment

330

Participants

Timeline

Start Date

September 20, 2024

Primary Completion Date

October 31, 2025

Study Completion Date

March 31, 2026

Conditions
Parkinson Disease
Interventions
DRUG

CVN424 75 mg

Participants will receive 75 mg CVN424 tablet once daily.

DRUG

CVN424 150 mg

Participants will receive 150 mg CVN424 tablet once daily.

DRUG

Placebo

Participants will receive matching placebo tablet once daily.

Trial Locations (41)

10021

RECRUITING

Weill Cornell Medical College, New York

11725

RECRUITING

Parkinson's Research Centers of America - Long Island, Commack

22031

RECRUITING

Inova Neurology - Fairfax, Fairfax

22042

RECRUITING

Inova Fairfax Medical Campus, Falls Church

23229

RECRUITING

Henrico Doctors Neurology Associates, LLC, Richmond

27607

RECRUITING

Raleigh Neurology Associates, Raleigh

RECRUITING

Velocity Clinical Research, Raleigh

27705

RECRUITING

Duke Neurology Morreene Road Clinic, Durham

32127

RECRUITING

University Clinical Research-DeLand, LLC d/b/a Accel Research Sites - Brain & Spine Institute, Port Orange

32751

RECRUITING

K2 Medical Research, Maitland

32825

RECRUITING

N1 Research LLc, Orlando

33486

RECRUITING

Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton

33487

RECRUITING

SFM Clinical Research, LLC, Boca Raton

33980

RECRUITING

Parkinson's Disease Center of SWFL, Port Charlotte

34471

RECRUITING

Renstar Medical Research, Ocala

35233

RECRUITING

The Kirklin Clinic of UAB Hospital, Birmingham

RECRUITING

University of Alabama at Birmingham, Birmingham

38157

RECRUITING

Veracity Neuroscience LLC, Memphis

40536

RECRUITING

University of Kentucky, Dept of Neurology Kentucky Neuroscience Institute Research, Lexington

43210

RECRUITING

The Ohio State University Wexner Medical Center, Columbus

43221

RECRUITING

The Ohio State University - Martha Morehouse Medical Plaza, Columbus

45212

RECRUITING

Riverhills Healthcare, Inc dba Riverhills Neuroscience, Cincinnati

48109

RECRUITING

University of Michigan Dept. of Neurology, Ann Arbor

RECRUITING

University of Michigan Hospital - Michigan Clinical Research Unit (MCRU), Ann Arbor

48334

RECRUITING

Quest Research Institute, Farmington Hills

53226

RECRUITING

Medical College of Wisconsin-Department of Neurology, Milwaukee

66160

RECRUITING

University of Kansas Medical Center, Kansas City

74136

RECRUITING

The Movement Disorder Clinic of Oklahoma, Tulsa

77030

RECRUITING

Houston Methodist Neurological Institute, Houston

77065

RECRUITING

Gill Neuroscience, Houston

77429

RECRUITING

Horizon Clinical Research Group, Cypress

78628

RECRUITING

Texas Movement Disorder Specialists, PLLC, Georgetown

78681

RECRUITING

Central Texas Neurology Consultants, Round Rock

80113

RECRUITING

CenExel Rocky Mountain Clinical Research, Englewood

94301

RECRUITING

Parkinson's Research Centers of America - Palo Alto, Palo Alto

99202

RECRUITING

Inland Northwest Research, Spokane

02131

RECRUITING

Boston Clinical Trials, Boston

08525

RECRUITING

Boro Neurology, Hopewell

NSW 2217

RECRUITING

Southern Neurology, Kogarah

NSW 2145

RECRUITING

Westmead Hospital-Department of Neurology, Sydney

WA 6009

RECRUITING

Perron Institute for Neurological and Translational Science, Nedlands

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Cerevance

INDUSTRY